Literature DB >> 2050146

Alpha-factor-leader-directed secretion of recombinant human-insulin-like growth factor I from Saccharomyces cerevisiae. Precursor formation and processing in the yeast secretory pathway.

K Steube1, B Chaudhuri, W Märki, J P Merryweather, J Heim.   

Abstract

A synthetic gene coding for human-insulin-like growth factor I (IGFI) was fused to the leader sequence of yeast prepro-alpha-factor and expressed in Saccharomyces cerevisiae under the control of a glyceraldehyde-3-phosphate dehydrogenase promoter fragment. Recombinant IGFI was found inside yeast cells and secreted into the medium. The secreted IGFI migrated on SDS gels with the same electrophoretic mobility as authentic IGFI, i.e. at about 7.5 kDa. HPLC analysis of secreted IGFI revealed the presence of the correctly folded, genuine molecule as well as an isomeric byproduct of equal molecular mass but with two of the three disulfide bonds interchanged. Inside exponentially growing cells the 7.5-kDa IGFI was also found, along with up to four additional IGFI-related polypeptides of higher molecular mass. By endoglycosidase F treatment the three polypeptides between 19-26 kDa were converted to a single peptide of 17 kDa. Since this peptide also reacted with an anti-alpha-factor antibody, it represents most likely the unglycosylated alpha-factor--IGFI fusion precursor. Pulse-chase experiments established the precursor nature of the intracellular higher-molecular-mass IGFI species. Conversion of the primary translation product to the differently glycosylated IGFI precursor proteins and into the mature form occurred very rapidly, within 2 min. Rapid maturation was, however, not followed by an equally rapid secretion of the mature form into the medium: only after 30-40 min did IGFI appear outside the cells. We therefore postulate the presence of an as yet undefined Golgi or post-Golgi bottleneck representing a major obstacle in secretion of recombinant IGFI from S. cerevisiae cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050146     DOI: 10.1111/j.1432-1033.1991.tb16063.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Overexpression of an anti-CD3 immunotoxin increases expression and secretion of molecular chaperone BiP/Kar2p by Pichia pastoris.

Authors:  Yuan Yi Liu; Jung Hee Woo; David M Neville
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

2.  Directed evolution of a secretory leader for the improved expression of heterologous proteins and full-length antibodies in Saccharomyces cerevisiae.

Authors:  J Andy Rakestraw; Stephen L Sazinsky; Andrea Piatesi; Eugene Antipov; K Dane Wittrup
Journal:  Biotechnol Bioeng       Date:  2009-08-15       Impact factor: 4.530

3.  In-vitro cleavage of a fusion protein bound to cellulose using the soluble yscFs (Kex2) variant.

Authors:  P G Seeboth; R A Warren; J Heim
Journal:  Appl Microbiol Biotechnol       Date:  1992-08       Impact factor: 4.813

4.  In-vitro processing of yeast alpha-factor leader fusion proteins using a soluble yscF (Kex2) variant.

Authors:  P G Seeboth; J Heim
Journal:  Appl Microbiol Biotechnol       Date:  1991-09       Impact factor: 4.813

5.  Improved secretion of native human insulin-like growth factor 1 from gas1 mutant Saccharomyces cerevisiae cells.

Authors:  M Vai; L Brambilla; I Orlandi; N Rota; B M Ranzi; L Alberghina; D Porro
Journal:  Appl Environ Microbiol       Date:  2000-12       Impact factor: 4.792

6.  Intracellular retention of newly synthesized insulin in yeast is caused by endoproteolytic processing in the Golgi complex.

Authors:  B Zhang ; A Chang; T B Kjeldsen; P Arvan
Journal:  J Cell Biol       Date:  2001-06-11       Impact factor: 10.539

7.  Expression of Recombinant Human Insulin-like Growth Factor Type 1 (rhIGF-1) in Escherichia coli.

Authors:  Hamidreza Iranpoor; Eskandar Omidinia; Venus Vatankhah; Vahid Gharanjik; Majid Shahbazi
Journal:  Avicenna J Med Biotechnol       Date:  2015 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.